Koninklijke Philips N.V.
Koninklijke Philips N.V. (PHG) Financial Performance & Income Statement Overview
Analyze Koninklijke Philips N.V. (PHG) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Koninklijke Philips N.V. (PHG) Income Statement & Financial Overview
Analyze Koninklijke Philips N.V.’s PHG earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.10B | $5.04B | $4.38B | $4.46B |
| Cost of Revenue | $2.25B | $3.08B | $2.37B | $2.47B |
| Gross Profit | $1.85B | $1.96B | $2.006B | $1.99B |
| Gross Profit Ratio | $0.45 | $0.39 | $0.46 | $0.45 |
| R&D Expenses | $457.00M | $472.00M | $433.00M | $424.00M |
| SG&A Expenses | $1.25B | $1.32B | $1.23B | $1.28B |
| Operating Expenses | $1.70B | $1.76B | $1.67B | $1.17B |
| Total Costs & Expenses | $3.94B | $4.84B | $4.04B | $3.65B |
| Interest Income | $33.00M | $5.00M | $34.00M | $20.00M |
| Interest Expense | $82.00M | $57.00M | $104.00M | $88.00M |
| Depreciation & Amortization | $276.00M | $0.00 | $14.00M | $319.00M |
| EBITDA | $462.00M | $172.00M | $351.00M | $744.00M |
| EBITDA Ratio | $0.11 | $0.03 | $0.08 | $0.17 |
| Operating Income | $154.00M | $200.00M | $337.00M | $816.00M |
| Operating Income Ratio | $0.04 | $0.04 | $0.08 | $0.18 |
| Other Income/Expenses (Net) | -$50.00M | -$85.00M | -$90.00M | -$160.00M |
| Income Before Tax | $104.00M | $115.00M | $247.00M | $656.00M |
| Income Before Tax Ratio | $0.03 | $0.02 | $0.06 | $0.15 |
| Income Tax Expense | $27.00M | $449.00M | $65.00M | $345.00M |
| Net Income | $76.00M | -$335.00M | $181.00M | $451.00M |
| Net Income Ratio | $0.02 | -$0.07 | $0.04 | $0.10 |
| EPS | $0.08 | -$0.36 | $0.20 | $0.50 |
| Diluted EPS | $0.08 | -$0.36 | $0.20 | $0.50 |
| Weighted Avg Shares Outstanding | $925.05M | $933.37M | $902.43M | $903.15M |
| Weighted Avg Shares Outstanding (Diluted) | $938.12M | $933.37M | $913.08M | $910.66M |
The company's financials show resilient growth, with revenue advancing from $4.46B in Q2 2024 to $4.10B in Q1 2025. Gross profit remained healthy with margins at 45% in Q1 2025 compared to 45% in Q2 2024. Operating income hit $154.00M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $462.00M. Net income rose to $76.00M, while earnings per share reached $0.08. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan